Literature DB >> 22855710

CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract.

David C Gondek1, Andrew J Olive, Georg Stary, Michael N Starnbach.   

Abstract

Chlamydia trachomatis infection is the most common bacterial sexually transmitted disease in the United States. Chlamydia infections that ascend to the upper genital tract can persist, trigger inflammation, and result in serious sequelae such as infertility. However, mouse models in which the vaginal vault is inoculated with C. trachomatis do not recapitulate the course of human disease. These intravaginal infections of the mouse do not ascend efficiently to the upper genital tract, do not cause persistent infection, do not induce significant inflammation, and do not induce significant CD4⁺ T cell infiltration. In this article, we describe a noninvasive transcervical infection model in which we bypass the cervix and directly inoculate C. trachomatis into the uterus. We show that direct C. trachomatis infection of the murine upper genital tract stimulates a robust Chlamydia-specific CD4⁺ T cell response that is both necessary and sufficient to clear infection and provide protection against reinfection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855710      PMCID: PMC3690950          DOI: 10.4049/jimmunol.1103032

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Chlamydia.

Authors:  Robert Belland; David M Ojcius; Gerald I Byrne
Journal:  Nat Rev Microbiol       Date:  2004-07       Impact factor: 60.633

Review 2.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.

Authors:  F O Eko; D N Okenu; U P Singh; Q He; C Black; J U Igietseme
Journal:  Vaccine       Date:  2011-03-21       Impact factor: 3.641

Review 4.  Development of a Chlamydia trachomatis T cell Vaccine.

Authors:  Karuna P Karunakaran; Hong Yu; Leonard J Foster; Robert C Brunham
Journal:  Hum Vaccin       Date:  2010-08-01

5.  Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during Chlamydia muridarum infection.

Authors:  Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Matthew A Zurenski; Toni Darville
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

6.  Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.

Authors:  Oretta Finco; Elisabetta Frigimelica; Francesca Buricchi; Roberto Petracca; Giuliano Galli; Elisa Faenzi; Eva Meoni; Alessandra Bonci; Mauro Agnusdei; Filomena Nardelli; Erika Bartolini; Maria Scarselli; Elena Caproni; Donatello Laera; Luisanna Zedda; David Skibinski; Serena Giovinazzi; Riccardo Bastone; Elvira Ianni; Roberto Cevenini; Guido Grandi; Renata Grifantini
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

7.  Identification of antigen-specific antibody responses associated with upper genital tract pathology in mice infected with Chlamydia muridarum.

Authors:  Hao Zeng; Siqi Gong; Shuping Hou; Quanming Zou; Guangming Zhong
Journal:  Infect Immun       Date:  2011-12-12       Impact factor: 3.441

8.  Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity.

Authors:  Sandra G Morrison; Christina M Farris; Gail L Sturdevant; William M Whitmire; Richard P Morrison
Journal:  J Infect Dis       Date:  2011-02-14       Impact factor: 5.226

9.  Two different homing pathways involving integrin β7 and E-selectin significantly influence trafficking of CD4 cells to the genital tract following Chlamydia muridarum infection.

Authors:  Kathleen A Kelly; Ann M Chan; Anthony Butch; Toni Darville
Journal:  Am J Reprod Immunol       Date:  2009-04-22       Impact factor: 3.886

10.  Compensatory T cell responses in IRG-deficient mice prevent sustained Chlamydia trachomatis infections.

Authors:  Jörn Coers; Dave C Gondek; Andrew J Olive; Amy Rohlfing; Gregory A Taylor; Michael N Starnbach
Journal:  PLoS Pathog       Date:  2011-06-23       Impact factor: 6.823

View more
  75 in total

1.  Integrin α4β1 is necessary for CD4+ T cell-mediated protection against genital Chlamydia trachomatis infection.

Authors:  Sergio J Davila; Andrew J Olive; Michael N Starnbach
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

2.  Human Fallopian Tube Epithelial Cell Culture Model To Study Host Responses to Chlamydia trachomatis Infection.

Authors:  Scott H Randell; Toni Darville; Uma M Nagarajan; Bryan E McQueen; Amy Kiatthanapaiboon; M Leslie Fulcher; Mariam Lam; Kate Patton; Emily Powell; Avinash Kollipara; Victoria Madden; Robert J Suchland; Priscilla Wyrick; Catherine M O'Connell; Boris Reidel; Mehmet Kesimer
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

3.  An Excess of the Proinflammatory Cytokines IFN-γ and IL-12 Impairs the Development of the Memory CD8+ T Cell Response to Chlamydia trachomatis.

Authors:  Xuqing Zhang; Michael N Starnbach
Journal:  J Immunol       Date:  2015-07-15       Impact factor: 5.422

4.  Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.

Authors:  Tara R Henning; Katherine Butler; Debra Hanson; Gail Sturdevant; Shanon Ellis; Elizabeth M Sweeney; James Mitchell; Frank Deyounks; Christi Phillips; Carol Farshy; Yetunde Fakile; John Papp; W Evan Secor; Harlan Caldwell; Dorothy Patton; Janet M McNicholl; Ellen Kersh
Journal:  J Infect Dis       Date:  2014-04-21       Impact factor: 5.226

Review 5.  Chemokine-mediated immune responses in the female genital tract mucosa.

Authors:  Maud Deruaz; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

6.  Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge.

Authors:  Nina Dieu Nhien Tran Nguyen; Anja W Olsen; Emma Lorenzen; Peter Andersen; Malene Hvid; Frank Follmann; Jes Dietrich
Journal:  NPJ Vaccines       Date:  2020-01-23       Impact factor: 7.344

7.  Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.

Authors:  Ali N Russell; Xiaojing Zheng; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Brandie D Taylor; Michelle D Picard; Jessica B Flechtner; Wujuan Zhong; Lauren C Frazer; Toni Darville
Journal:  J Infect Dis       Date:  2016-10-12       Impact factor: 5.226

8.  Chlamydia trachomatis-induced alterations in the host cell proteome are required for intracellular growth.

Authors:  Andrew J Olive; Madeleine G Haff; Michael J Emanuele; Laura M Sack; Jeffrey R Barker; Stephen J Elledge; Michael N Starnbach
Journal:  Cell Host Microbe       Date:  2014-01-15       Impact factor: 21.023

9.  A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.

Authors:  Weidang Li; Ashlesh K Murthy; Gopala Krishna Lanka; Senthilnath L Chetty; Jieh-Juen Yu; James P Chambers; Guangming Zhong; Thomas G Forsthuber; M Neal Guentzel; Bernard P Arulanandam
Journal:  Vaccine       Date:  2013-10-01       Impact factor: 3.641

10.  A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.

Authors:  Taylor B Poston; Yanyan Qu; Jenna Girardi; Catherine M O'Connell; Lauren C Frazer; Ali N Russell; McKensie Wall; Uma M Nagarajan; Toni Darville
Journal:  J Immunol       Date:  2017-08-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.